Re: | AllianceBernstein Holding L.P. |
1. | We note issuance of AllianceBernstein Holding L.P. (“AB Holding”) units in the amount of $108.0 million and the corresponding increase in the limited partners’ capital which was used to fund long-term incentive compensation plan awards granted by AllianceBernstein L.P. and Subsidiaries (“AB”). Tell us if you (AB Holding) considered any amount of the distribution to be a dividend to AXA Equitable Life Insurance (“AXA”), considering AXA controls both AB Holding and AB. In this regard, clarify the accounting guidance used by AB to support their accounting treatment (e.g. ASC 718, ASC 505-50, or ASC 815). |
Ÿ | AB legally makes the grant of the stock-based awards to its employees and would receive back any units not earned by employees; |
Ÿ | AB purchases newly-issued AB Holding Units from AB Holding or AB Holding Units on the open market; |
Ÿ | The General Partner is the same for AB Holding and AB; |
Ÿ | AB Holding and AB have contractual symmetry of AB Units held by AB Holding to AB Holding Units issued by AB Holding; |
Ÿ | AB Holding has no economic purpose as a stand-alone entity; and |
Ÿ | The grant of an AB Holding Unit by AB, as a practical matter, is the same as a grant of an AB Unit, in that AB Holding Units and AB Units represent interests in the same underlying business on a one-to-one basis. |
2. | We note from your disclosure on page 77 (Note 2 – Summary of Significant Accounting Policies, Long-term Incentive Compensation Plans) that AB Holding unit awards (vested and unvested) pay distributions to participants on a quarterly basis and these awards are not forfeitable. We also note from the table on page 97 (Note 17 – Long-term Incentive Compensation Plans) that 20.7 million shares of unvested restricted AB Holding units are outstanding at year end. Please respond to the following: |
Ÿ | Tell us whether the restricted AB Holding units meet the definition of a participating security as defined at ASC 260-10-20. |
Ÿ | Provide us with your EPS calculations under the two-class method as required by ASC 260-10-45-60A, if applicable, and revise your filings if EPS amounts under the two-class method are materially different than the amounts previously disclosed. |
Ÿ | In light of the items noted above, revise your future filings (as necessary) to describe your accounting policy for calculating EPS under the two-class method and expand your policy for other methods considered in your calculation of diluted EPS (i.e. treasury stock method). |
3. | We note that you hold restricted units in a rabbi trust. We also note from your disclosure on page 69 (Consolidated Statements of Changes in Partners’ Capital) that you reclassified liability-based awards to equity in previous accounting periods but ceased reclassification in 2014. Please respond to the following: |
Ÿ | If true, confirm that you no longer identify your awards as liability-based. In your response, explain to us the driver of this change and indicate if the timing of the participant allocations of their awards into restricted units or deferred cash was the catalyst of this change (i.e. allocations made before or after the grant date). |
Ÿ | Tell us the type(s) of rabbi trust plan(s) you held for each period presented (i.e. Plan A, Plan B, etc.) Refer to ASC 710-10-25-15. |
Ÿ | Tell us whether the liability-based awards were considered in your calculation of EPS, and if not, explain to us why the liability would not be factored into your EPS calculation. Refer to ASC 260-10-60-1 and ASC 710-10-45. |
4. | We note that you hold a material amount of trading securities at the end of each reporting period. Please revise your future filings to present the trading gains and losses related to your trading securities held at the end of each reporting period. Refer to ASC 320-10-50-9(e) and 50-14. |
Three Months Ended March 31,
|
||||||||
2015
|
2014
|
|||||||
(in thousands)
|
||||||||
Net gains recognized during the period
|
$
|
6,784
|
$
|
14,812
|
||||
Less: net gains recognized during the period on trading securities sold during the period
|
6,047
|
4,404
|
||||||
Unrealized gains recognized during the period on trading securities held
|
$
|
737
|
$
|
10,408
|
5. | We note that you present derivative assets and liabilities on your balance sheet within receivables and payables to brokers and dealers, respectively. We also note from your disclosure on page 84 (Note 9 – Fair Value) that you have derivative assets and liabilities classified as exchange traded options within trading securities and securities sold not yet purchased. Please respond to the following: |
Ÿ | For all of your derivative instruments, revise your future filings to present the location and amount of gains and losses reported in your financial statements. Refer to ASC 815-10-50-4A(b). |
Ÿ | For your derivative instruments classified as trading securities, revise your future filings to present these instruments within your derivative disclosures of confirm, if true, that you have elected an exemption under which allows you to include these instruments within your trading activities. |
Ÿ | If you have elected the exemption noted in the previous bullet point, revise your future filings to disclose your election of this exemption and present the financial performance of all of your trading activities. Refer to ASC 815-10-50-4F and ASC 815-10-55-184. |
6. | We note from your disclosure on page 74 (Note 2 – Summary of Significant Accounting Policies) that your securities borrowed and loaned are reported within your receivables from and payables to brokers and dealers on your balance sheet, respectively. We also note from your disclosure on page 82 (Note 7 – Derivative Instruments) that certain derivative contracts are subject to master netting arrangements. Please revise your future filings to present all financial instruments (i.e. derivative assets and liabilities, securities borrowed and loaned, etc.) within this tabular disclosure. Refer to ASC 815-10-50-7A and ASC 210-20-50-1 through 50-6. |
Gross Amounts of Recognized Assets
|
Gross Amounts Offset in the Statement of Financial Position
|
Net Amounts of Assets Presented in the Statement of Financial Position
|
Financial Instruments
|
Cash Collateral Received
|
Net Amount
|
|||||||||||||||||||
(in thousands)
|
||||||||||||||||||||||||
March 31, 2015:
|
||||||||||||||||||||||||
Securities borrowed
|
$
|
157,916
|
$
|
—
|
$
|
157,916
|
$
|
—
|
$
|
(157,916
|
)
|
$
|
—
|
|||||||||||
Derivatives
|
$
|
8,551
|
$
|
—
|
$
|
8,551
|
$
|
—
|
$
|
(1,078
|
)
|
$
|
7,473
|
|||||||||||
Long exchange- traded options
|
$
|
6,767
|
$
|
—
|
$
|
6,767
|
$
|
—
|
$
|
—
|
$
|
6,767
|
||||||||||||
December 31, 2014:
|
||||||||||||||||||||||||
Securities borrowed
|
$
|
158,147
|
$
|
—
|
$
|
158,147
|
$
|
—
|
$
|
(158,147
|
)
|
$
|
—
|
|||||||||||
Derivatives
|
$
|
6,787
|
$
|
—
|
$
|
6,787
|
$
|
—
|
$
|
(990
|
)
|
$
|
5,797
|
|||||||||||
Long exchange- traded options
|
$
|
22,290
|
$
|
—
|
$
|
22,290
|
$
|
—
|
$
|
—
|
$
|
22,290
|
Gross Amounts of Recognized Liabilities
|
Gross Amounts Offset in the Statement of Financial Position
|
Net Amounts of Liabilities Presented in the Statement of Financial Position
|
Financial Instruments
|
Cash Collateral Pledged
|
Net Amount
|
|||||||||||||||||||
(in thousands)
|
||||||||||||||||||||||||
March 31, 2015:
|
||||||||||||||||||||||||
Securities loaned
|
$
|
2,184
|
$
|
—
|
$
|
2,184
|
$
|
—
|
$
|
(2,184
|
)
|
$
|
—
|
|||||||||||
Derivatives
|
$
|
9,773
|
$
|
—
|
$
|
9,773
|
$
|
—
|
$
|
(9,773
|
)
|
$
|
—
|
|||||||||||
Short exchange- traded options
|
$
|
5,602
|
$
|
—
|
$
|
5,602
|
$
|
—
|
$
|
—
|
$
|
5,602
|
||||||||||||
December 31, 2014:
|
||||||||||||||||||||||||
Securities loaned
|
$
|
33,645
|
$
|
—
|
$
|
33,645
|
$
|
—
|
$
|
(33,645
|
)
|
$
|
—
|
|||||||||||
Derivatives
|
$
|
9,392
|
$
|
—
|
$
|
9,392
|
$
|
—
|
$
|
(9,392
|
)
|
$
|
—
|
|||||||||||
Short exchange- traded options
|
$
|
7,118
|
$
|
—
|
$
|
7,118
|
$
|
—
|
$
|
—
|
$
|
7,118
|
7. | Please revise your future filings to present your contingent payment arrangements (i.e. acquisition related liabilities) within your fair value disclosures or explain to us the guidance that exempts you from this disclosure requirement. Refer to ASC 820-10-50. |
Level 1
|
Level 2
|
Level 3
|
Total
|
|||||||||||||
March 31, 2015:
|
||||||||||||||||
Money markets
|
$
|
172,415
|
$
|
—
|
$
|
—
|
$
|
172,415
|
||||||||
U.S. Treasury Bills
|
—
|
499,059
|
—
|
499,059
|
||||||||||||
Available-for-sale
|
||||||||||||||||
Equity securities
|
6,136
|
—
|
—
|
6,136
|
||||||||||||
Fixed income securities
|
306
|
—
|
—
|
306
|
||||||||||||
Trading
|
||||||||||||||||
Equity securities
|
334,792
|
24,680
|
122
|
359,594
|
||||||||||||
Fixed income securities
|
183,227
|
3,086
|
—
|
186,313
|
||||||||||||
Long exchange-traded options
|
6,767
|
—
|
—
|
6,767
|
||||||||||||
Derivatives
|
360
|
8,191
|
—
|
8,551
|
||||||||||||
Private equity
|
13,885
|
—
|
58,719
|
72,604
|
||||||||||||
Total assets measured at fair value
|
$
|
717,888
|
$
|
535,016
|
$
|
58,841
|
$
|
1,311,745
|
||||||||
Securities sold not yet purchased
|
||||||||||||||||
Short equities – corporate
|
$
|
61,302
|
$
|
—
|
$
|
—
|
$
|
61,302
|
||||||||
Short exchange-traded options
|
5,602
|
—
|
—
|
5,602
|
||||||||||||
Derivatives
|
3,011
|
6,762
|
—
|
9,773
|
||||||||||||
Contingent payment arrangements
|
—
|
—
|
42,223
|
42,223
|
||||||||||||
Total liabilities measured at fair value
|
$
|
69,915
|
$
|
6,762
|
$
|
42,223
|
$
|
118,900
|
December 31, 2014:
|
||||||||||||||||
Money markets
|
$
|
89,566
|
$
|
—
|
$
|
—
|
$
|
89,566
|
||||||||
U.S. Treasury Bills
|
—
|
444,152
|
—
|
444,152
|
||||||||||||
Available-for-sale
|
||||||||||||||||
Equity securities
|
5,951
|
—
|
—
|
5,951
|
||||||||||||
Fixed income securities
|
221
|
—
|
—
|
221
|
||||||||||||
Trading
|
||||||||||||||||
Equity securities
|
387,495
|
7
|
—
|
387,502
|
||||||||||||
Fixed income securities
|
164,317
|
2,742
|
—
|
167,059
|
||||||||||||
Long exchange-traded options
|
22,290
|
—
|
—
|
22,290
|
||||||||||||
Derivatives
|
571
|
6,216
|
—
|
6,787
|
||||||||||||
Private equity
|
12,162
|
—
|
58,926
|
71,088
|
||||||||||||
Total assets measured at fair value
|
$
|
682,573
|
$
|
453,117
|
$
|
58,926
|
$
|
1,194,616
|
||||||||
Securities sold not yet purchased
|
||||||||||||||||
Short equities – corporate
|
$
|
81,784
|
$
|
—
|
$
|
—
|
$
|
81,784
|
||||||||
Short exchange-traded options
|
7,118
|
—
|
—
|
7,118
|
||||||||||||
Derivatives
|
2,438
|
6,954
|
—
|
9,392
|
||||||||||||
Contingent payment arrangements
|
—
|
—
|
42,436
|
42,436
|
||||||||||||
Total liabilities measured at fair value
|
$
|
91,340
|
$
|
6,954
|
$
|
42,436
|
$
|
140,730
|
• | Money markets: We invest excess cash in various money market funds that are valued based on quoted prices in active markets; these are included in Level 1 of the valuation hierarchy. |
• | Treasury Bills: We hold U.S. Treasury Bills, which are primarily segregated in a special reserve bank custody account as required by Rule 15c3-3 of the Exchange Act. These securities are valued based on quoted yields in secondary markets and are included in Level 2 of the valuation hierarchy. |
• | Equity and fixed income securities: Our equity and fixed income securities consist principally of company-sponsored mutual funds with net asset values and various separately-managed portfolios consisting primarily of equity and fixed income securities with quoted prices in active markets, which are included in Level 1 of the valuation hierarchy. In addition, some securities are valued based on observable inputs from recognized pricing vendors, which are included in Level 2 of the valuation hierarchy. |
• | Derivatives: We hold exchange-traded futures with counterparties that are included in Level 1 of the valuation hierarchy. In addition, we also hold currency forward contracts, interest rate swaps, credit default swaps, option swaps and total return swaps with counterparties that are included in Level 2 of the valuation hierarchy. |
• | Options: We hold long exchange-traded options that are included in Level 1 of the valuation hierarchy. |
•
|
Private equity: Generally, the valuation of private equity investments owned by our consolidated venture capital fund or by us directly (regarding an investment in a private equity fund focused exclusively on the energy sector) requires significant management judgment due to the absence of quoted market prices, inherent lack of liquidity and the long-term nature of such investments. Private equity investments are valued initially at cost. The carrying values of private equity investments are adjusted either up or down from cost to reflect expected exit values as evidenced by financing and sale transactions with third parties, or when determination of a valuation adjustment is confirmed through ongoing review in accordance with our valuation policies and procedures. A variety of factors are reviewed and monitored to assess positive and negative changes in valuation, including current operating performance and future expectations of investee companies, industry valuations of comparable public companies, changes in market outlooks, and the third party financing environment over time. In determining valuation adjustments resulting from the investment review process, particular emphasis is placed on current company performance and market conditions. For these reasons, which make the fair value of private equity investments unobservable, equity investments are included in Level 3 of the valuation hierarchy. We also invest in a third-party venture capital fund in which fair value is based on our capital account balance provided by the partnership and is included in Level 3 of the valuation hierarchy. If private equity investments owned by our consolidated venture capital fund become publicly-traded, they are included in Level 1 of the valuation hierarchy. Also, if they contain trading restrictions, publicly-traded equity investments are included in Level 2 of the valuation hierarchy. During the first quarter of 2015, $26,000 was transferred from a Level 3 classification to a Level 1 classification.
|
• | Securities sold not yet purchased: Securities sold not yet purchased, primarily reflecting short positions in equities and exchange-traded options, are included in Level 1 of the valuation hierarchy. |
• | Contingent payment arrangements: Contingent payment arrangements relate to contingent payment liabilities associated with acquisitions in 2010, 2013 and 2014. At each reporting date, we estimate the fair values of the contingent consideration expected to be paid based upon probability-weighted AUM and revenue projections, using unobservable market data inputs, which are included in Level 3 of the valuation hierarchy. |
Three Months Ended March 31,
|
||||||||
2015
|
2014
|
|||||||
(in thousands)
|
||||||||
Balance as of beginning of period
|
$
|
42,436
|
$
|
38,205
|
||||
Accretion
|
443
|
321
|
||||||
Payments
|
(656
|
)
|
(838
|
)
|
||||
Balance as of end of period
|
$
|
42,223
|
$
|
37,688
|
8. | We note that the significant increases in your projected benefit obligation and accumulated other comprehensive loss appear to be driven by changes in your discount rate and mortality assumptions. We also note from your previous Form 10-K that you amortized $0.5 million of loss from accumulated other comprehensive income to earnings in 2014 and will amortize $1.0 million of loss in 2015. Please respond to the following: |
Ÿ | Tell us the amortization period over which you will amortize these losses. Refer to ASC 715-30-35-24. |
Ÿ | Provide us with a reconciliation of the amounts recognized in other comprehensive income on page 92 to the amounts presented in your statement of comprehensive income on page 68. |
Ÿ | Revise your future filings to clearly present within your Consolidated Statements of Comprehensive Income (page 68) the amounts of employee benefit related items reclassified out of accumulated comprehensive income and into earnings. Refer to ASC 220-10-45. |
AB changes in employee benefit related items:
|
Note 16 - Retirement Plan
|
Medical Plan
|
Retired
Individual
Plan
|
Foreign
Retirement
Plans
|
OCI
Statement
|
|||||||||||||||
(in thousands)
|
||||||||||||||||||||
Amortization of prior service cost
|
$
|
-
|
$
|
(5,197
|
)
|
$
|
-
|
$
|
-
|
$
|
(5,197
|
)
|
||||||||
Recognized actuarial (loss) gain
|
(20,803
|
)
|
1,476
|
(226
|
)
|
(103
|
)
|
(19,656
|
)
|
|||||||||||
Changes in employee benefit related items
|
(20,803
|
)
|
(3,721
|
)
|
(226
|
)
|
(103
|
)
|
(24,853
|
)
|
||||||||||
Income tax benefit (expense)
|
232
|
49
|
2
|
15
|
298
|
|||||||||||||||
Employee benefit related items, net of tax
|
$
|
(20,571
|
)
|
$
|
(3,672
|
)
|
$
|
(224
|
)
|
$
|
(88
|
)
|
$
|
(24,555
|
)
|
Ÿ | AB Holding and AB are responsible for the adequacy and accuracy of the disclosure in their respective filings; |
Ÿ | Staff comments or changes to disclosure in response to staff comments do not foreclose the Commission from taking any action with respect to the filings; and |
Ÿ | AB Holding and AB may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. |
/s/ John C. Weisenseel
|
|
John C. Weisenseel
|
|
Chief Financial Officer
|
|
AllianceBernstein Holding L.P. and AllianceBernstein L.P.
|